Healthy Chinese Volunteers
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
LP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Lee's PharmaceuticalTecarfarin
AstellasYM178
Clinical Trials (2)
Total enrollment: 64 patients across 2 trials
An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers
Start: Apr 2020Est. completion: Dec 202040 patients
Phase 1Unknown
Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers
Start: May 2012Est. completion: Aug 201224 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space